• Latest Posts

New epilepsy study could lead to new treatment options

Europe approves childhood epilepsy treatment

Metrion and KCNC1 Foundation announce collaboration to identify therapeutic

Neuraxpharm’s expansion into the Netherlands takes it from two to 20 countries in six years


UCB publishes Lennox-Gastaut syndrome study data

Researchers awarded £2M to develop drugs to prevent epileptic seizures in children 

More News! 26 Oct 2022

Neuraxpharm to commercialize device giving early warning of epileptic seizures

Epilepsy drug accepted for review in Canada and Israel

New treatment option available for Dravet syndrome

Spanish Neurology Biotech Launches with €7.6M Series A